Healthy
Conditions
Keywords
short message service; adherence; stent exchange; ERCP
Brief summary
Plastic and covered metal stents need to be removed or exchanged within appropriate time in case of undesirable complications. However, it is not uncommon that patients does not follow the recommendation for further stent management after ERCP. we hopothesized that short message service (SMS) intervention monthly could improve the adherence in patients with benign pancreaticobiliary after ERCP.
Interventions
OTHERshort message service group
Each month after stent implantation, the investigator sent a text message by SMS to inform patients the necessity of regular stent removal/exchange and the disadvantage of delayed management, and to remind them the appropriate date to come back to the hospital for stent management. Patients were requested to respond by SMS and were encouraged to contact the investigator if they had any questions about stent management. Besides, patients received conventional reminder:After stent implantation, all patients received oral and written instructions about further management. If single or multiple plastic stents were inserted, patients were informed to come back to the hospital at 3 months for stent removal/exchange; if FCSEMS was inserted, they were informed to come back to the hospital at 6 months after ERCP.
OTHERconventional group
After stent implantation, all patients received oral and written instructions about further management. If single or multiple plastic stents were inserted, patients were informed to come back to the hospital at 3 months for stent removal/exchange; if FCSEMS was inserted, they were informed to come back to the hospital at 6 months after ERCP.
Sponsors
Air Force Military Medical University, China
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* be able to communicate via SMS by mobile phones of themselves or relatives living together
Exclusion criteria
* primary or secondary sclerosing cholangitis (PSC) * malignant or suspected malignant stricture of biliary or pancreatic duct * implantation of pancreatic duct (PD) stent for prevention of post-ERCP pancreatitis * expected survival time less than 6 months * plan of surgery within 6 months * pregnant or lactating women * patients who could not give informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adherence rate of biliary stent removal/exchange | up to 1 year | Percentage of patients adherence to stent removal/exchange within appropriate time |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Stent-associated adverse event | 1 year | Percentage of patients with stent-related adverse events, including cholangitis, stent migration and abdominal pain |
Countries
China
Outcome results
None listed